SCHEMBL1464686

SCHEMBL1464686

C=CC(O)C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10524293 0.97 TP53 (0.41)
SCHEMBL2511775 0.97 TP53 (0.41)
SCHEMBL8764246 0.88 UGT2B7 (0.32)
SCHEMBL1471843 0.88
SCHEMBL130488 0.88
SCHEMBL7802318 0.78 UGT2B7 (0.31)
SCHEMBL8718770 0.77 ALDH1A1 (0.38)
SCHEMBL7586183 0.77 CPN1 (0.35)
SCHEMBL6112257 0.77
SCHEMBL17292929 0.77 BCL2A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020445-B1 FUSED PYRIDINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2008-08-13 EP claimed
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives EISAI CO., LTD. 2004-10-14 US claimed
US-6790844-B2 MUSCLE RELAXANTS; ANTISEROTONINE AGENT EISAI CO., LTD (JP) 2004-09-14 US claimed
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US claimed
US-6340759-B1 ANTISPASMODIC AGENTS EISAI CO., LTD. (JP) 2002-01-22 US claimed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP claimed
US-8268835-B2 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same PFIZER INC. (US) 2012-09-18 US disclosed
US-8268835-B2 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same PFIZER INC. (US) 2012-09-18 US disclosed
US-8268835-B2 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same PFIZER INC. (US) 2012-09-18 US disclosed
EP-1781662-B1 INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME PFIZER (US) 2011-04-20 EP disclosed
US-20110070187-A1 Methods for the Preparation of HCV Polymerase Inhibitors PFIZER INC. 2011-03-24 US disclosed
US-20110070187-A1 Methods for the Preparation of HCV Polymerase Inhibitors PFIZER INC. 2011-03-24 US disclosed
US-20110070187-A1 Methods for the Preparation of HCV Polymerase Inhibitors PFIZER INC. 2011-03-24 US disclosed
CN-1308649-A Catalyst system based on transition metal complexes for the copolymerization of carbon monoxide in an aqueous medium BASF AG (DE) 2001-08-15 CN disclosed
EP-1091995-A1 CATALYST SYSTEMS ON THE BASIS OF TRANSITION METAL COMPLEXES FOR CARBON MONOXIDE COPOLYMERISATION IN AN AQUEOUS MEDIUM BASF AKTIENGESELLSCHAFT (DE) 2001-04-18 EP disclosed
EP-1091967-A1 WATER-SOLUBLE TRANSITION METAL COMPLEXES BASF AKTIENGESELLSCHAFT (DE) 2001-04-18 EP disclosed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP disclosed
WO-2000001708-A1 WATER-SOLUBLE TRANSITION METAL COMPLEXES BASF AKTIENGESELLSCHAFT (DE) 2000-01-13 WO disclosed
WO-2000001756-A1 CATALYST SYSTEMS ON THE BASIS OF TRANSITION METAL COMPLEXES FOR CARBON MONOXIDE COPOLYMERISATION IN AN AQUEOUS MEDIUM BASF AKTIENGESELLSCHAFT (DE) 2000-01-13 WO disclosed
US-3880883-A 2-(Hydroxyalkyl)-cyclopentane carbaldehydes MAY & BAKER LTD 1975-04-29 US disclosed